| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.09 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.09 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |